New serological markers in medical mycology: (1,3) –B-D-glucan and Aspergillus galactomannan
Invasive fungal infections present a great challenge in modern medicine. The recent development of serologic markers represents a clear advance in the field. Two serological tests have been developed: (1,3)-β-D glucan and Aspergillus galactomannan. This review discusses highlights of both tests.
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2012 |
| País: | Argentina |
| Institución: | Consejo Nacional de Investigaciones Científicas y Técnicas |
| Repositorio: | CONICET Digital (CONICET) |
| Idioma: | inglés |
| OAI Identifier: | oai:ri.conicet.gov.ar:11336/197789 |
| Acceso en línea: | http://hdl.handle.net/11336/197789 |
| Access Level: | acceso abierto |
| Palabra clave: | ASPERGILLUS GALACTOMANNAN FUNGAL INFECTIONS SEROLOGICAL TESTS https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
| Sumario: | Invasive fungal infections present a great challenge in modern medicine. The recent development of serologic markers represents a clear advance in the field. Two serological tests have been developed: (1,3)-β-D glucan and Aspergillus galactomannan. This review discusses highlights of both tests. |
|---|